Lifetime Cost-effectiveness of Oral Semaglutide Versus Dulaglutide and Liraglutide in Patients With Type 2 Diabetes Inadequately Controlled With Oral Antidiabetics
Nancy Risebrough, Timothy Baker, Lirong Zhang, Sarah Ali, Michael Radin, Tam Dang‐Tan
Topics & Concepts
SemaglutideMedicineLiraglutideDulaglutideType 2 diabetesDiabetes mellitusInternal medicineEndocrinologyDiabetes Treatment and ManagementHyperglycemia and glycemic control in critically ill and hospitalized patientsDiabetes Management and Research